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Abstract Cellophane wrapping of the hamster pancreas induces 
islet neogenesis. We have used the mRNA differential display 
technique to select for genes expressed uring islet neogenesis but 
not in control pancreata. Ten candidate clones have been identi- 
fied. Upon sequencing, 6 clones showed a high degree of homology 
to known genes, 1 showed some, and 3 showed no homology to 
genes of known sequence. Thus, mRNA differential display is a 
useful technique to identify genes induced during islet neogenesis, 
and in combination with screening hamster pancreatic cDNA 
libraries for full length clones, will enhance the likelihood of 
capturing the participants in this process. 
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1. Introduction 
We have reported previously that cellophane wrapping (CW) 
of the hamster pancreas induces islet neogenesis from pancre- 
atic ductal cells which are capable of proliferating and differen- 
tiating upon stimulation into adult islets capable of secreting 
insulin in a fully regulated manner [1 3]. The appearance of islet 
cell hormones in the duct of CW pancreata reiterates that seen 
during normal pancreatic embryogenesis (glucagon message 
preceding insulin message, and glucagon protein preceding in- 
sulin protein) [4]. This process involves activation of genes to 
initiate proliferation, differentiation and growth of stem cells. 
Much is known about other cell types such as bone marrow 
stem cells [5], but little is known about pancreatic islets. Eluci- 
dation of the genes that are activated in the pancreatic islet 
regenerative process has only begun. It is hoped that identifying 
these genes will provide new insights into the mechanisms in- 
volved in the islet regenerative process. 
One approach to identifying and characterizing the genes 
responsible for regeneration is to compare those expressed in 
sham-operated versus CW pancreata. The identification of al- 
terations in gene expression induced by CW has been under- 
taken primarily by the 'candidate gene' approach [1,6]. These 
methods only permit screening of known molecules on an indi- 
vidual basis but fail to identify new genes that function to 
regulate growth in these specific circumstances. A promising 
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new technique called mRNA differential display (DD) has been 
recently described and used to identify differences in subsets of 
mRNA samples [7 9]. The key element of this technique is to 
use sets of anchored and arbitrary primers to generate cDNA 
fragments by reverse transcription, followed by polymerase 
chain reaction (RT-PCR). The cDNA fragments are resolved 
and compared on sequencing els. The resulting cDNA pat- 
terns reflect differences in the mRNA levels and composition 
between control and experimental nimals. Theoretical calcula- 
tions and experimental results confirm that the method can 
indeed generate patterns of bands which might represent al- 
most all expressed genes in a particular cell [10]. Differentially 
displayed cDNAs are isolated, cloned, sequenced and used as 
probes on Northern blots to confirm differences in the particu- 
lar mRNA level. This method has the advantage of being very 
sensitive, reproducible and can detect quantitative as well as 
qualitative changes in gene expression [11,12]. 
We report here the use and validation of this method to study 
differential gene expression in the CW-induced pancreatic islet 
regeneration and the isolation of 10 clones uniquely or differen- 
tially expressed in the regenerating pancreas. 
2. Materials and methods 
2.1. Experimental pproach 
We used reverse transcription-PCR of genes differentially expressed 
in pancreata undergoing islet neogenesis. The templates used were total 
RNA pooled from both control and wrapped hamster pancreata. 
Pooled pancreata were used to exclude differences in the level of gene 
expression resulting from variable degrees of islet regeneration i  the 
different animals. Those cDNA bands demonstrating differential ex- 
pression were isolated and used directly from PCR reamplification as
probes on Northern blots to confirm the differential expression between 
CW and control non-regenerating tissue. The samples in which differ- 
ential expression was confirmed were subcloned and Northern results 
reconfirmed. Northern blots shown in the text are derived from these 
subclones. The differentially expressed clones were further subjected to 
sequence analysis. 
2.2. Isolation of differentially expressed mRNAs 
Differential display was performed as described [9]. Total cellular 
RNA was isolated from control and CW hamster pancreas using the 
guanidine isothiocyanate method [13]. Four reverse transcription reac- 
tions were performed for each RNA sample using 0.2 Bg of DNA-free 
total RNA in 1 x reverse transcription buffer, 25 /IM each dGTR 
dATE dCTE dTTP, 1/IM of either T12VG, T12VA, T12VC or T12VT 
(where V is 3-fold degenerate for G, A and C) and 100 units of moloney 
murine leukemia virus (M-MLV) reverse transcriptase (RT) and incu- 
bation at 37°C for I h. This reaction was performed in duplicate in 
order to minimize rrors in the PCR procedure and appearance of false 
positive bands. The resulting cDNA was amplified using the PCR with 
0.2,uM 10met arbitrary primers, 1x PCR buffer, 1 jIM of the respective 
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T12VN, 2,uM dNTPs, 2 units of AmpliTaq DNA polymerase (Boehrin- 
ger-Mannheim, Indianapolis, IN) and 10 ,uCi [35S]dATR The cycling 
parameters were as follows: 94°C for 30 s, 40°C for 2 min, 72°C for 
30 s for 40 cycles followed by 72°C for 7 min. To assure that the RNA 
samples did not have any remaining chromosomal DNA contamination 
we performed the PCR reaction in the absence of reverse transcriptase 
which resulted in complete disappearance of bands in the display. The 
amplified cDNAs were then separated on a 6% DNA sequencing el. 
Bands showing differential expression were cut out and DNA was 
eluted and reamplified using appropriate primers and conditions de- 
scribed above except no radioisotope was added. The PCR product was 
visualized on a 1.5% agarose gel to verify size, eluted and used for 
subcloning or Northern blot analysis. Reamplified cDNAs were cloned 
into the PCR II vector using the TA cloning kit (Invitrogen, San Diego, 
CA) and digested with EeoRI to confirm the size of cDNA inserts. 
Clones that showed positive Northern blot analysis were sequenced 
using TaqTrack sequencing system (Promega, Madison, WI) and ana- 
lyzed on a 8 M urea/6% acrylamide DNA sequencing gel. The cDNAs 
sequences were compared to those contained in the GENEBank and 
EMBL data base (PC/Gene by IntelliGenetics). 
2.3. Quantification fgene expression by Northern blot analysis 
For Northern blotting, 30 gg of heat denatured total RNA were 
separated on a 1.2% agarose, 0.6% formaldehyde/MOPS denaturing 
gel, transferred to nylon membrane (Nytran, Schleicher & Schuell, 
Keene, NH) and immobilized by baking at 80°C. cDNA probes used 
in Northern hybridization were labeled through the incorporation of 
[a32p]dCTP (Dupont-New England Nuclear, Boston, MA) using ran- 
dom primed synthesis to a specific activity of >1 x 109cpm/ug. A 
[732p]ATP (Dupont-New England Nuclear) 5'-end-labeled 24mer syn- 
thetic oligonucleotide for 18S was used as a loading control. Prehybridi- 
zation and hybridization buffers consisted of 50% formamide, 
5 x SSPE, 1% SDS, 5 x Denhardt's, and 200 gg/ml denatured salmon 
sperm DNA. Prehybridizations were performed at 50°C for 4 h and 
hybridizations at50°C for 16-18 h with 1-5 x 106 cpm/ml of the appro- 
priate radiolabeled probe. Washes were performed twice for 15 min 
each in 6 x SSPE 0.1% SDS at 25°C; 1 x SSPE 0.1% SDS at 37°C; and 
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Fig. 2. Northern blot analysis of differential display clones. Heat-dena- 
tured total RNA derived from 10 pooled control (C) and cellophane 
wrapped (W) pancreata were separated on 1.2% agarose gel and trans- 
ferred to Nytran nylon membrane. [32p]dCTP-labeled cDNA probes 
were used to hybridize to the membrane. Bottom panel: the same 
membrane r probed with a Y-end-labeled 24mer synthetic oligonucleo- 
tide for the 18S ribosomal mRNA as a loading control. The location 
of the transcripts i indicated. 
under stringent conditions in 0.1 x SSPE 0.1% SDS at 65°C. Autoradi- 
ography was performed at -80°C for 1 h to 5 days by exposing scientific 
imaging film (X-Omat/AR, Kodak, Rochester, NY). 
Fig. 1. mRNA differential display. Each primer combination displayed 
100-200 bands. Candidate cDNAs which demonstrated altered expres- 
sion between control (C) and cellophane wrapped (W) are marked by 
arrows. 
3. Results 
3.1. Uniquely expressed mRNAs in the CW pancreas detected 
by mRNA differential display 
RNA isolated from non-wrapped pancreas and 2-day 
wrapped pancreas were used in an attempt o isolate putative 
genes involved in pancreatic islet neogenesis. For  each RNA,  
80 combinat ions of primer sets made of 4 degenerate anchored 
oligo(dT) primers, T12MA, T12MC, T12MG,  or T12MT, and 
20 decamer arbitrary primers (AP1-20) were used for RT-PCR 
to obtain differential display bands. Reactions were performed 
in duplicate, and those showing uniquely expressed bands in the 
wrapped pancreas were repeated to ensure reproducibility. 
Twenty-five fragments were uniquely expressed in the 2-day 
wrapped pancreas (Fig. 1). These fragments were reamplified 
and used as probes in Northern hybridization. 
R. Rafaeloff et al./FEBS Letters 378 (1996) 219-223 221 
~_ ~t~ 
*-" t~ "O 
t-- "O 
O O 
O t~ v-- 
3.3. Temporal expression of the candidate genes in the hamster 
pancreas 
To delineate the phase of islet regeneration i which the 
candidate genes might be involved, we performed temporal 
gene expression experiments hat demonstrated that there was 
a slightly increased expression of RD85 after wrapping which 
progressed with time (Fig. 4A). Expression of RD3-2 mRNA 
peaked at 24  days and decreased to control evel thereafter 
(Fig. 4B). Expression of B7-1, B8-1 and B10-2 was increased 
at 12 h to 4 days, markedly decreased at 6 days and was absent 
from all other samples (Fig. 4C). B9-5 expression was absent 
from control non-wrapped samples but was increased at 1, 2 
and 4 days after CW and disappeared thereafter (Fig. 4D). 
Increased expression of RD6-3 was observed at 6 and 10 days 
after cellophane wrapping (Fig. 3). Expression of RD19-2 was 
maximal at 1-2 days of CW without expression at any other 
time point (Fig. 5). 
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Fig. 3. Silver-stained polyacrylamide g l showing RD6-3 gene xpres- 
sion in whole pancreas from control animals and after 6 and 10 days 
of wrapping. PCR was performed using 2 mg of total RNA under 
conditions described in section 2. Aliquots of the amplified products 
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3.2. Quantification and sequence analysis of difJbrentially 
expressed mRNAs in the CW pancreas 
Northern blot analysis confirmed unique or differential ex- 
pression of 9 out of 25 candidate genes in wrapped pancreas: 
RD3-2, RD19-2, B7-1, B8-1, B9-5, B10-2, RD85, RD86 and 
RD88 (Fig. 2). Six failed to detect any signal, and the remaining 
10 were false positive. The cDNAs which failed to detect any 
signal were sequenced and PCR amplified using specific prim- 
ers; however, only 1 showed any signal after amplification, 
RD6-3 (Fig. 3). The remainder continued to be undetectable, 
presumable due to very low mRNA levels. The 10 candidate 
clones were individually subcloned into the TA cloning vector. 
For reconfirmation, Northern blots were screened using 3zp_ 
labeled DNA from both the PCR fragments and subcloned 
inserts with equivalent results. Upon sequencing and compari- 
son of the 10 clones with the GenBank database, 6 clones 
showed very high homology to known genes: RD3-2 corre- 
sponded to cytochrome c oxidase; RD6-3 corresponded to 
ubiquitin conjugating enzyme; RD85 corresponded to elastase 
I and B7-1, B8-1 and B10-2 corresponded to Reg family of 
genes. Due to the area of the sequence (being in the 3'-end) and 
size, we cannot conclude whether it is Reg-I or Reg-H gene. One 
clone, RD19-2, showed some homology to the Reg and PAP 
family of genes, and the remaining 3 showed no homology to 
any known genes. 
C . . . .  ~ , ,  .......... ~:~T:~,!!~Ii~U~j~ ~ 






Fig. 4. Northern blot analysis of candidate genes in pancreatic tissue 
from control and CW hamster. Heat-denatured total RNA derived 
from control and cellophane wrapped pancreata were separated on 
1.2% agarose gel and transferred to Nytran nylon membrane. 
[32p]dCTP-labeled cDNA probes were used to hybridize to the mem- 
brane. Membranes were hybridized with a 490 bp hamster RD85 
cDNA probe (A), a 300 bp hamster RD3-2 cDNA probe (B), a 326 bp 
hamster B8-1 cDNA probe (C), a 326 bp hamster B9-5 cDNA probe 
(D), and an 18S ribosomal 24mer synthetic oligonucleotide probe to 
control for RNA integrity and loading (E). The location of the tran- 
scripts is indicated. 
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Fig. 5. Northern blot analysis of RDl9-2 in pancreatic tissue from 
control and CW hamster. Heat-denatured total RNA derived from 
control and cellophane wrapped pancreata were separated on 1.2% 
agarose gel and transferred to Nytran nylon membrane. A 420 bp 
[32P]dCTP-labeled hamster RD 19-2 cDNA probe was used to hybridize 
to the membrane (A). Same membrane r probed with a 5'-end-labeled 
24mer synthetic oligonucleotide for the 18S ribosomal mRNA as a 
loading control (B). The location of the 0.9 kb RD19-2 transcript is 
indicated. 
4. Discussion 
Taken together, the results how that 80% (20/25) of candi- 
date genes isolated by differential rnRNA display resulted in 
transcripts detectable on Northern analysis. However, only 
40% (10/25) were mRNA species differentially expressed in 
regenerating wrapped pancreas, while 40% (10/25) were false 
positive, the same level of expression being detected in control 
and regenerating pancreas. Thus, there were 10 mRNA species 
uniquely or differentially expressed in CW pancreata. 
All 10 uniquely expressed clones were sequenced and com- 
pared to the GenBank and EMBL databases. Three of the 10 
mRNA species identified showed no homology to any DNA 
sequence deposited in the DNA databases. The uniquely or 
differentially expressed cDNA clones were assigned the follow- 
ing identification numbers: RD19-2, B7-1, B8-1, B9-5, B10-2, 
RD85, RD86, RD88, RD3-2 and RD6-3. The unique expres- 
sion of RD19-2, B7-1, B8-1, B9-5 and B10-2 clones in CW but 
not in control pancreata could indicate a particular role that 
these genes might play in the initiation or perpetuation of the 
regeneration process itself or simply as markers for cell prolif- 
eration. 
Clones B7-1, B8-1 and B10-2 showed a high degree of homol- 
ogy to the 3'-end of Reg gene which has been found in regener- 
ating islets [14,15] and regenerating wrapped pancreas [6]. Reg 
protein has been shown, under certain circumstances, to be able 
to initiate cell growth in the rat [16]. Reg is thought o be 
identical to the pancreatic stone protein (PSP) [17] and pancre- 
atic thread protein (PTP) [18] whose putative function is to 
inhibit calcium lithiasis in the exocrine pancreas [19]. Thus, it 
is not clear that the increased expression is a function of growth 
or an anti-inflammatory response. Clone RD19-2 has shown 
some homology to the pancreatitis associated protein (PAP) 
and Reg families of genes [14 21], but further studies in our 
laboratory have shown it to be a novel gene associated with islet 
neogenesis whose protein product can initiate proliferation of 
proto-undifferentiated c lls [22]. Clone RD85 was found to 
have very high homology to pancreatic elastase 1gene and its 
expression was progressively increased with time after the sur- 
gical procedure. A possible xplanation for the slight increase 
in elastase gene expression with time would be the fact that in 
response to CW there is also an increase in the acinar tissue 
mass along with the increase in islet tissue. Clone RD6-3 which 
showed higher expression in wrapped regenerating pancreas 
than in control, showed 90% homology to ubiquitin (Ub) con- 
jugating enzyme which has been reported to play a crucial role 
in the progression of the cell cycle from the G1 to S phase [23]. 
It therefore appears that we have identified genes that may 
be implicated in the orchestrated transformation f proto-un- 
differentiated cells into mature adult islets. Since our model is 
one of induced cell proliferation and differentiation, such find- 
ings add validation to our approach for revealing enes in- 
volved in this entire process. The mRNA differential display is 
a useful technique for identifying differentially expressed genes 
in regenerating vs. non-regenerating pancreata which, in com- 
bination with screening hamster pancreatic libraries for full- 
length clones, enhances the likelihood of capturing the elusive 
participants in this process. 
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